Stock listing

NASDAQ:MORF Morphic Holding Inc Stock

Follow Morphic Holding Inc into a list and get an email when it puts out news.

Last close · NASDAQ:MORF

$56.99 USD

Close on Aug 16, 2024 · No longer trades

Jun 27, 2019 to last close +216.6% · weekly closes, Jun 27, 2019 – Aug 16, 2024
Lowest – highest close
$10.84 – $84.85 USDSince Jun 27, 2019 · lowest Mar 16, 2020 · highest Mar 1, 2021

Delisted NASDAQ:MORF no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:MORF
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Morphic Holding Inc on 6ix

Calls
1 call with a replay · 1 with a transcript · latest Mar 1, 2021
Decks
6 decks · latest Mar 12, 2024

Events

CallWhenStatus
Morphic Holding (MORF) Q4 2020 Earnings CallMon, Mar 01, 2021 · 8:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (March 2024)Investor deck38 slidesMar 12, 2024
Technical Presentation (October 2023)Technical32 slidesOct 12, 2023
Technical Presentation (April 2023)Technical16 slidesApr 25, 2023
Investor Presentation (September 2020)Investor deck22 slidesSep 23, 2020
Cowen 40th Annual Healthcare Conference (March 2020)Conference20 slidesMar 4, 2020
JP Morgan Healthcare Conference 2020Conference28 slidesJan 13, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Susannah Gray
Other companies: AnaptysBio, Inc. (Director · Since at least Mar 26, 2026); Maravai LifeSciences Holdings, Inc. (Director · Since at least May 23, 2024); 4D Molecular Therapeutics, Inc. (Director · Since at least May 21, 2024); Theravance Biopharma, Inc. (Director · Since at least May 8, 2024)
Director · Jun 4, 2024 – Aug 16, 2024 · Past
Praveen Tipirneni
Other companies: BridgeBio Oncology Therapeutics, Inc. (Non-Executive Director · Since at least Aug 11, 2025); Tectonic Therapeutic, Inc. (Director · Since at least Jun 20, 2024); Panacea Acquisition II Corp (Director · Apr 6, 2021 – Apr 6, 2021 · Past)
President and CEO, Director · Jun 26, 2019 – Aug 16, 2024 · Past
Nilesh Kumar
Other companies: Checkmate Pharmaceuticals Inc (Director · Aug 6, 2020 – Aug 6, 2020 · Past); Milestone Pharmaceuticals Inc. (Director · May 8, 2019 – May 8, 2019 · Past)
Director · Jun 26, 2019 – Jun 26, 2019 · Past
Marc Schegerin
Other companies: ArQule Inc (CFO and Treasurer · Mar 30, 2019 – Jan 16, 2020 · Past)
CFO and COO · Apr 6, 2020 – Aug 16, 2024 · Past
Alexey LugovskoyChief Development Officer · Jun 26, 2019 – Nov 9, 2020 · Past
Bruce RogersPRESIDENT · Jan 12, 2024 – Aug 16, 2024 · Past
William DeVaulGeneral Counsel and Secretary · Jun 26, 2019 – Aug 16, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Morphic Holding Inc.